Transgenic mouse models for tumors of melanocytes and retinal pigment epithelium

Citation
F. Beermann et al., Transgenic mouse models for tumors of melanocytes and retinal pigment epithelium, PIGM CELL R, 12(2), 1999, pp. 71-80
Citations number
71
Categorie Soggetti
Cell & Developmental Biology
Journal title
PIGMENT CELL RESEARCH
ISSN journal
08935785 → ACNP
Volume
12
Issue
2
Year of publication
1999
Pages
71 - 80
Database
ISI
SICI code
0893-5785(199904)12:2<71:TMMFTO>2.0.ZU;2-X
Abstract
Cutaneous and ocular melanomas are due to malignant transformation of neura l crest-derived melanocytes. The rising incidence of this tumor in humans h as stimulated experiments to devise suitable mouse models. In the past year s, transgenic mouse lines have been generated using different oncogenes - H a-ras, SV40 T antigen (Tag), ret - which develop benign lesions of melanocy tes, melanoma, and/or eye tumors. Pigment cell tumors in humans, although r ather rare, can also develop from the retinal pigment epithelium (RPE), a c ell layer of neuroectodermal origin. We, therefore, established transgenic models for this ocular tumor. Regulated by the promoter of tyrosinase-relat ed protein-1 (TRP-1), two oncogenes, ret and SV40 Tag, were targeted to the developing RPE in transgenic mice. The TRP-1/ret transgenic mice displayed microphthalmia and benign tumors of the RPE. Expression of SV40 T antigen (TRP-1/Tag) led to malignant tumors, which were invasive and metastasized t o inguinal lymph node and spleen.